I haven't followed Advanced Cell's journey in about 6 months but am happy to catch up on them today after so long. I always liked them but the well known issues forced me to pan them each time I looked at them.
After reading the last 80 or so posts, I would encourage patience. They have a very positive future IF they can execute a secondary without too much dilution and get started with the Ph 2. Dilution being a sore point to long time investors here, for sure. I'm not concerned with the uplist because those things take care of themselves when they are executing their plan and have catalysts to drive the price.
My feeling is that things are not as bad OR as good as some make have made them out to be, and that the encouraging science will prevail with institutional investors because it gives them valid reasons to be optimistic about success. That's the perspective of someone who knows their past, been away for a while, but has come back with fresh eyes and likes what he sees.
News 
Market Data 
Discover 
AI
